At Bumame, our purpose is to elevate healthcare in Indonesia by bridging the gap between cutting-edge technologies and accessible care, empowering lives through customer-centric innovations.

We have partnered with best-in-class world leading strategic partners, introducing revolutionary medical services and adapting them to suit the unique needs of the Indonesian market.

Bumame was founded early in 2020, in response to the Covid-19 pandemic. Building on our rapid rise as the #1 provider of COVID-19 services in Indonesia during the pandemic, we've pivoted to revolutionize other critical areas. Today, we're:

• Indonesia's #1 provider of Non-Invasive Prenatal Test (NIPT)
• Utilizing high-throughput sequencing platforms, providing next generation sequencing services 
• Expanding our reach through a comprehensive portfolio of both routine pathology and specialized diagnostic solution
• Pioneering advancements and affordable commercialization of world-class tests, with a focus on Mother & Child and Early Cancer Screening
• Lead and manage analytical and clinical validation research services

Our digital-first approach and best-in-class service set us apart. We're changing the standard of care delivery, poised to lead the Indonesian healthcare transformation.

Join us: If you're passionate about delivering exceptional patient experiences and shaping the future of healthcare, let's connect!

Health Diagnostics

Health Services

Health Care

Biotechnology

Bumame

James Wihardja

Iqbal Adhika

Gaby Sastramihardja

Melvi Melvi

Benz Budiman

Herbert Raditya

Rina S.

Bumame

Org chart

Similar companies